Leonard Kaizer

1.3k total citations
27 papers, 667 citations indexed

About

Leonard Kaizer is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leonard Kaizer has authored 27 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leonard Kaizer's work include Clinical practice guidelines implementation (7 papers), Cancer Treatment and Pharmacology (6 papers) and Nausea and vomiting management (4 papers). Leonard Kaizer is often cited by papers focused on Clinical practice guidelines implementation (7 papers), Cancer Treatment and Pharmacology (6 papers) and Nausea and vomiting management (4 papers). Leonard Kaizer collaborates with scholars based in Canada, New Zealand and United States. Leonard Kaizer's co-authors include Norman F. Boyd, David Tritchler, David Warr, Valentina Kriukov, David Osoba, Joseph L. Pater, Jean Latreille, Benny Zee, Monika K. Krzyzanowska and Sean Hopkins and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and The Oncologist.

In The Last Decade

Leonard Kaizer

27 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonard Kaizer Canada 11 267 183 146 120 102 27 667
Erin L. Ashbeck United States 19 129 0.5× 268 1.5× 107 0.7× 76 0.6× 96 0.9× 46 865
M’Balu A. Webb United Kingdom 12 352 1.3× 190 1.0× 54 0.4× 92 0.8× 71 0.7× 21 678
Derya Koçer Türkiye 14 138 0.5× 84 0.5× 73 0.5× 66 0.6× 45 0.4× 39 883
I M Lee United States 7 72 0.3× 114 0.6× 117 0.8× 148 1.2× 73 0.7× 7 804
Álex de la Sierra Spain 12 122 0.5× 251 1.4× 54 0.4× 46 0.4× 80 0.8× 16 830
James Speirs United States 14 349 1.3× 59 0.3× 66 0.5× 90 0.8× 62 0.6× 22 779
C. Sirolla Italy 15 142 0.5× 41 0.2× 217 1.5× 88 0.7× 57 0.6× 35 859
Mariola Śliwińska‐Mossoń Poland 13 150 0.6× 118 0.6× 74 0.5× 33 0.3× 104 1.0× 42 653
Eric T.P. Keulen Netherlands 17 189 0.7× 497 2.7× 204 1.4× 70 0.6× 30 0.3× 46 1.0k
Katsunori ISHIKAWA Japan 14 179 0.7× 37 0.2× 159 1.1× 65 0.5× 61 0.6× 46 832

Countries citing papers authored by Leonard Kaizer

Since Specialization
Citations

This map shows the geographic impact of Leonard Kaizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Kaizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Kaizer more than expected).

Fields of papers citing papers by Leonard Kaizer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard Kaizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Kaizer. The network helps show where Leonard Kaizer may publish in the future.

Co-authorship network of co-authors of Leonard Kaizer

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard Kaizer. A scholar is included among the top collaborators of Leonard Kaizer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard Kaizer. Leonard Kaizer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaizer, Leonard, et al.. (2016). Using Data From Ontario’s Episode-Based Funding Model to Assess Quality of Chemotherapy. Journal of Oncology Practice. 12(10). e870–e877. 2 indexed citations
2.
Kaizer, Leonard, et al.. (2014). International Efforts in Health Care Reform: Systemic Treatment Funding Model Reform in Ontario. Journal of Oncology Practice. 10(3). 190–192. 2 indexed citations
3.
Ahmad, Noor Ani, et al.. (2014). Oral chemotherapy practices at Ontario cancer centres. Journal of Oncology Pharmacy Practice. 21(4). 249–257. 10 indexed citations
4.
5.
Gavura, Scott, et al.. (2014). Enhancing the delivery of take-home cancer therapies in Ontario.. Journal of Clinical Oncology. 32(30_suppl). 46–46. 2 indexed citations
6.
Kaizer, Leonard, et al.. (2013). Concordance with best-practice guidelines for systemic treatment computerized prescriber order entry systems.. Journal of Clinical Oncology. 31(31_suppl). 245–245. 1 indexed citations
7.
Clemons, Mark, et al.. (2013). Lost in Transition? Thoughts on Retirement—“Will You Still Need Me, Will You Still Feed Me, When I'm Sixty-Four?”. The Oncologist. 18(11). 1235–1238. 4 indexed citations
8.
Bak, Kate, Eric Gutierrez, Elizabeth Lockhart, et al.. (2013). Use of Continuous Infusion Pumps During Radiation Treatment. Journal of Oncology Practice. 9(2). 107–111. 4 indexed citations
9.
Kaizer, Leonard, Monika K. Krzyzanowska, John R. Srigley, et al.. (2012). Patient-centered wait time measurement in Ontario.. Journal of Clinical Oncology. 30(34_suppl). 233–233. 1 indexed citations
10.
Cheung, Winson Y., Gregory R. Pond, M. Rother, et al.. (2008). Adherence to Surveillance Guidelines After Curative Resection for Stage II/III Colorectal Cancer. Clinical Colorectal Cancer. 7(3). 191–196. 24 indexed citations
11.
Lachaîne, Jean, et al.. (2005). Chemotherapy-Induced Emesis: Quality of Life and Economic Impact in the Context of Current Practice in Canada. PubMed. 2(3). 181–187. 40 indexed citations
12.
Goss, Paul E., Kathrin Strasser, Mark Clemons, et al.. (2000). Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer. Breast Cancer Research and Treatment. 64(2). 177–188. 16 indexed citations
13.
Goss, Paul E., A. Keith Stewart, Félix Couture, et al.. (1999). Combined Results of Two Phase Il Studies of Taxol (Paclitaxel) in Patients with Relapsed or Refractory Lymphomas. Leukemia & lymphoma. 34(3-4). 295–304. 13 indexed citations
14.
Osoba, David, Benny Zee, David Warr, et al.. (1997). Effect of postchemotherapy nausea and vomiting on health-related quality of life. Supportive Care in Cancer. 5(4). 307–313. 170 indexed citations
15.
Osoba, David, Benny Zee, David Warr, et al.. (1996). Quality of Life Studies in Chemotherapy-Induced Emesis. Oncology. 53(1). 92–95. 66 indexed citations
16.
Moore, Malcolm J., Leonard Kaizer, Charles Erlichman, et al.. (1995). A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal caner. Cancer Chemotherapy and Pharmacology. 37(1-2). 86–90. 5 indexed citations
17.
Erlichman, Charles, et al.. (1994). Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer. Breast Cancer Research and Treatment. 30(2). 205–209. 9 indexed citations
18.
Warr, David, Peter Venner, Joseph L. Pater, et al.. (1993). A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. European Journal of Cancer. 29(1). 33–36. 29 indexed citations
19.
Kaizer, Leonard, Norman F. Boyd, Valentina Kriukov, & David Tritchler. (1989). Fish consumption and breast cancer risk: An ecological study. Nutrition and Cancer. 12(1). 61–68. 170 indexed citations
20.
Kaizer, Leonard, E Fishell, J.W. Hunt, F. Stuart Foster, & Norman F. Boyd. (1988). Ultrasonographically defined parenchymal patterns of the breast: relationship to mammographic patterns and other risk factors for breast cancer. British Journal of Radiology. 61(722). 118–124. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erin L. Ashbeck Breakdown of academic impact, for papers by M’Balu A. Webb Breakdown of academic impact, for papers by Derya Koçer Breakdown of academic impact, for papers by I M Lee Breakdown of academic impact, for papers by Álex de la Sierra Breakdown of academic impact, for papers by James Speirs Breakdown of academic impact, for papers by C. Sirolla Breakdown of academic impact, for papers by Mariola Śliwińska‐Mossoń Breakdown of academic impact, for papers by Eric T.P. Keulen Breakdown of academic impact, for papers by Katsunori ISHIKAWA
Rankless by CCL
2026